Average Co-Inventor Count = 5.04
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Alnylam Pharmaceuticals, Inc. (45 from 444 patents)
2. Novartis Ag (5 from 3,923 patents)
3. US Government As Represented by the Secretary of the Army (4 from 8,684 patents)
4. The University of Texas System (4 from 5,450 patents)
5. Arrowhead Pharmaceuticals, Inc. (4 from 96 patents)
6. Ludwig Institute for Cancer Research Limited (3 from 525 patents)
7. The Scripps Research Institute (1 from 1,187 patents)
8. Arrowhead Research Corporation (1 from 18 patents)
9. The United States of America As Represented by the Army (1 from 3 patents)
55 patents:
1. 11208662 - RNAi inhibition of alpha-ENaC expression
2. 10544418 - RNAi inhibition of alpha-ENaC expression
3. 10501742 - Compositions and methods for inhibiting expression of the PCSK9 gene
4. 9957507 - Compositions and methods for inhibiting expression of mutant EGFR gene
5. 9914927 - RNAi inhibition of alpha-ENaC expression
6. 9822365 - Compositions and methods for inhibiting expression of the PCSK9 gene
7. 9506067 - Compositions and methods for inhibiting expression of the HAMP gene
8. 9476052 - RNAi inhibition of alpha-ENaC expression
9. 9260718 - Compositions and methods for inhibiting expression of the PCSK9 gene
10. 9212364 - Compositions and methods for inhibiting expression of mutant EGFR gene
11. 9187516 - Compositions and methods for inhibiting expression of a gene from the Ebola virus
12. 9102940 - RNAi modulation of SCAP and therapeutic uses thereof
13. 9090895 - Compositions and methods for inhibiting expression of the HAMP gene
14. 9074212 - RNAi inhibition of alpha-ENaC expression
15. 9057069 - Compositions and methods for inhibiting expression of Eg5 gene